BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 24495796)

  • 21. TGF-β-induced differentiation into myofibroblasts involves specific regulation of two MKL1 isoforms.
    Scharenberg MA; Pippenger BE; Sack R; Zingg D; Ferralli J; Schenk S; Martin I; Chiquet-Ehrismann R
    J Cell Sci; 2014 Mar; 127(Pt 5):1079-91. PubMed ID: 24424023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.
    Kalashnikova EV; Revenko AS; Gemo AT; Andrews NP; Tepper CG; Zou JX; Cardiff RD; Borowsky AD; Chen HW
    Cancer Res; 2010 Nov; 70(22):9402-12. PubMed ID: 20864510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.
    Cai D; Cao J; Li Z; Zheng X; Yao Y; Li W; Yuan Z
    BMC Cancer; 2009 Apr; 9():102. PubMed ID: 19338666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic molecular classification of breast cancers based on gene expression profiling].
    Feng YM; Li XQ; Sun BC; Gao XC; Gu L; Niu Y; Hao XS
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):900-6. PubMed ID: 17533740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene-induced senescence.
    Hampl V; Martin C; Aigner A; Hoebel S; Singer S; Frank N; Sarikas A; Ebert O; Prywes R; Gudermann T; Muehlich S
    EMBO Mol Med; 2013 Sep; 5(9):1367-82. PubMed ID: 23853104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MKL1 mediates TGF-beta1-induced alpha-smooth muscle actin expression in human renal epithelial cells.
    Elberg G; Chen L; Elberg D; Chan MD; Logan CJ; Turman MA
    Am J Physiol Renal Physiol; 2008 May; 294(5):F1116-28. PubMed ID: 18337547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
    Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
    Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone methyltransferase SMYD3 promotes MRTF-A-mediated transactivation of MYL9 and migration of MCF-7 breast cancer cells.
    Luo XG; Zhang CL; Zhao WW; Liu ZP; Liu L; Mu A; Guo S; Wang N; Zhou H; Zhang TC
    Cancer Lett; 2014 Mar; 344(1):129-137. PubMed ID: 24189459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of tenascin-C inhibits breast cancer cells development by cell growth, migration, and adhesion impairment.
    Wawrzyniak D; Grabowska M; Głodowicz P; Kuczyński K; Kuczyńska B; Fedoruk-Wyszomirska A; Rolle K
    PLoS One; 2020; 15(8):e0237889. PubMed ID: 32817625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells.
    Chiovaro F; Martina E; Bottos A; Scherberich A; Hynes NE; Chiquet-Ehrismann R
    Int J Cancer; 2015 Oct; 137(8):1842-54. PubMed ID: 25868708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.
    Zabouo G; Imbert AM; Jacquemier J; Finetti P; Moreau T; Esterni B; Birnbaum D; Bertucci F; Chabannon C
    Breast Cancer Res; 2009; 11(1):R1. PubMed ID: 19123925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma.
    Deng R; Huang JH; Wang Y; Zhou LH; Wang ZF; Hu BX; Chen YH; Yang D; Mai J; Li ZL; Zhang HL; Huang Y; Peng XD; Feng GK; Zhu XF; Tang J
    Mol Cancer; 2020 Aug; 19(1):122. PubMed ID: 32771023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional activity of megakaryoblastic leukemia 1 (MKL1) is repressed by SUMO modification.
    Nakagawa K; Kuzumaki N
    Genes Cells; 2005 Aug; 10(8):835-50. PubMed ID: 16098147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231.
    Morini M; Astigiano S; Gitton Y; Emionite L; Mirisola V; Levi G; Barbieri O
    BMC Cancer; 2010 Nov; 10():649. PubMed ID: 21108812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers.
    Wendt MK; Taylor MA; Schiemann BJ; Sossey-Alaoui K; Schiemann WP
    Breast Cancer Res; 2014 Mar; 16(2):R24. PubMed ID: 24618085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
    J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression profiling changes induced by a novel Gemini Vitamin D derivative during the progression of breast cancer.
    Lee HJ; Liu H; Goodman C; Ji Y; Maehr H; Uskokovic M; Notterman D; Reiss M; Suh N
    Biochem Pharmacol; 2006 Jul; 72(3):332-43. PubMed ID: 16737686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional profiling of ErbB signalling in mammary luminal epithelial cells--interplay of ErbB and IGF1 signalling through IGFBP3 regulation.
    Worthington J; Bertani M; Chan HL; Gerrits B; Timms JF
    BMC Cancer; 2010 Sep; 10():490. PubMed ID: 20840765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear accumulation of MKL1 in luminal breast cancer cells impairs genomic activity of ERα and is associated with endocrine resistance.
    Jehanno C; Fernandez-Calero T; Habauzit D; Avner S; Percevault F; Jullion E; Le Goff P; Coissieux MM; Muenst S; Marin M; Michel D; Métivier R; Flouriot G
    Biochim Biophys Acta Gene Regul Mech; 2020 May; 1863(5):194507. PubMed ID: 32113984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
    Shats I; Gatza ML; Liu B; Angus SP; You L; Nevins JR
    Cancer Res; 2013 Oct; 73(19):6056-67. PubMed ID: 23966291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.